Clinical Trial

Perioperative Topical Nepafenac After Epiretinal Membrane Surgery

Study acronym: NEPERM
Completed Phase 4
View on ClinicalTrials.gov →
Summary
This prospective comparative study evaluates whether perioperative topical nepafenac improves early anatomical and functional recovery after pars plana vitrectomy with epiretinal membrane and internal limiting membrane peeling. The study compares postoperative visual acuity, central macular thickness, and other clinical outcomes between patients treated with perioperative nepafenac and those receiving standard postoperative care.
Trial Details
NCT Number NCT07736690
Lead Sponsor Ankara Yildirim Beyazıt University
Conditions Epiretinal Membrane, Macular Pucker
Enrollment 60 participants
Start Date 2024-01-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-30